It's no longer a matter of which company will achieve the highest hepatitis C cure rates first, but which one will most effectively treat patients who fall through the cracks, since Gilead Sciences Inc., Merck & Co. Inc. and AbbVie Inc.'s latest antiviral drug cocktails cure nearly all patients.
Data presented during the European Association of the Study of the Liver's (EASL's) International Liver Congress from April 13 to...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
